Skip to content
Nonprofiteer
← MYOSITIS ASSOCIATION

Form 990 for tax year 2023

Filed by MYOSITIS ASSOCIATION.

Totals

Total revenue
$1,249,899
Total expenses
$1,888,477
Contributions and grants received
$1,189,812
Grants paid
$228,536
Program service revenue
$84,124
Investment income
-$10,414
Other revenue
-$13,623
Total assets, end of year
$1,779,524
Total liabilities, end of year
$489,420
Net assets or fund balances, end of year
$1,290,104
Program services expenses (Part IX)
$1,197,234
Management and general expenses
$542,671
Fundraising expenses
$148,572
Program service expenses (Part III)
$1,197,234

Program services were 63.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $2,009

  • 1f · All other contributions, gifts and grants

    $1,187,803

  • 2a · Program service revenue: Outlook Advertising

    total $3,500 · unrelated business $3,500

  • 2b · Program service revenue: Patient Conferences

    total $80,624 · related or exempt $80,624

  • 3 · Investment income

    total $34,494 · excluded $34,494

  • 4 · Income from investment of tax-exempt bond proceeds

    total $0

  • 5 · Royalties

    total $0

  • 6d · Net rental income or loss

    total $0

  • 7a · Gross sales of assets other than inventory

    securities $595,051 · other assets $550

  • 7b · Less cost or other basis and sales expenses

    securities $638,556 · other assets $1,953

  • 7c · Gain or loss

    securities -$43,505 · other assets -$1,403

  • 7d · Net gain or loss

    total -$44,908 · related or exempt -$44,908

  • 8c · Net income from fundraising events

    total $0

  • 9c · Net income from gaming

    total $0

  • 10a · Gross sales of inventory

    $16,722

  • 10b · Cost of goods sold

    $30,345

  • 10c · Net income from sales of inventory

    total -$13,623 · excluded -$13,623

  • 11e · Other revenue, total

    $0

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $152,000 · program services $152,000

  • 2 · Grants to domestic individuals

    total $1,093 · program services $1,093

  • 3 · Grants to foreign organizations and individuals

    total $75,443 · program services $75,443

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $235,401 · program services $26,621 · management and general $203,456 · fundraising $5,324

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $226,272 · program services $198,608 · management and general $13,661 · fundraising $14,003

  • 8 · Pension plan contributions

    total $3,248 · program services $2,775 · management and general $237 · fundraising $236

  • 9 · Other employee benefits

    total $31,379 · program services $26,807 · management and general $2,293 · fundraising $2,279

  • 10 · Payroll taxes

    total $22,493 · program services $20,411 · management and general $530 · fundraising $1,552

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $20,708 · management and general $20,708

  • 11c · Fees: accounting

    total $86,526 · management and general $86,526

  • 11d · Fees: lobbying

    total $0

  • 11e · Fees: professional fundraising services

    total $0

  • 11f · Fees: investment management

    total $12,670 · management and general $12,670

  • 11g · Fees: other

    total $397,101 · program services $135,624 · management and general $148,677 · fundraising $112,800

  • 12 · Advertising and promotion

    total $7,979 · program services $7,952 · management and general $27

  • 13 · Office expenses

    total $102,060 · program services $70,390 · management and general $29,740 · fundraising $1,930

  • 14 · Information technology

    total $42,408 · program services $36,992 · management and general $2,716 · fundraising $2,700

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $87,114 · program services $74,423 · management and general $6,365 · fundraising $6,326

  • 17 · Travel

    total $26,261 · program services $24,365 · management and general $1,770 · fundraising $126

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $327,917 · program services $327,917

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $10,121 · program services $8,646 · management and general $740 · fundraising $735

  • 23 · Insurance

    total $3,669 · program services $3,135 · management and general $268 · fundraising $266

  • 24a · Other expenses: Licenses & Fees

    total $11,990 · management and general $11,990

  • 24b · Other expenses: Dues & Subscriptions

    total $4,624 · program services $4,032 · management and general $297 · fundraising $295

  • 24e · All other expenses

    total $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $104,705 · end of year $53,430

  • 2 · Savings and temporary cash investments

    beginning of year $160,751 · end of year $11,088

  • 3 · Pledges and grants receivable

    end of year $0

  • 4 · Accounts receivable

    beginning of year $140,278 · end of year $43,000

  • 5 · Loans and receivables from officers and key people

    end of year $0

  • 6 · Loans and receivables from disqualified persons

    end of year $0

  • 7 · Other notes and loans receivable

    end of year $0

  • 8 · Inventories for sale or use

    end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $32,043 · end of year $34,101

  • 10a · Land, buildings and equipment: cost or other basis

    $108,653

  • 10b · Land, buildings and equipment: accumulated depreciation

    $85,442

  • 10c · Land, buildings and equipment, net

    beginning of year $31,825 · end of year $23,211

  • 11 · Investments: publicly traded securities

    beginning of year $1,429,455 · end of year $1,237,590

  • 12 · Investments: other securities

    end of year $0

  • 13 · Investments: program-related

    end of year $0

  • 14 · Intangible assets

    end of year $0

  • 15 · Other assets

    beginning of year $428,885 · end of year $377,104

  • 17 · Accounts payable and accrued expenses

    beginning of year $116,293 · end of year $98,484

  • 25 · Other liabilities

    beginning of year $458,242 · end of year $390,936

  • 27 · Net assets without donor restrictions

    beginning of year $1,549,641 · end of year $1,100,057

  • 28 · Net assets with donor restrictions

    beginning of year $203,766 · end of year $190,047

Mission and programs · 2023

Mission

The mission of The Myositis Association, or TMA, is: to improve the lives of persons affected by myositis, fund innovative research, and increase myositis awareness and advocacy. TMA is the premier international organization providing important resources, education and support to those in the myositis community. This community consists of children, adults, and their families who live with the daunting and life-changing physical, psychological and emotional effects of myositis. Nationwide, an estimated 75,000 Americans are affected by this collection of rare diseases. Symptoms of myositis include, but are not limited to: muscle weakness; pain; fatigue; tripping or falling; trouble swallowing; difficulty breathing; and irritations of the skin, joints, and eyes. Myositis is often difficult to diagnose, because many physicians are unfamiliar with the disease and its symptoms. Also, as a rare disease, it can be difficult to enroll enough patients to conduct adequate research of new treatmen

Activities or mission (Part I)

In 2023, The Myositis Association (TMA) celebrated our 30th year of service to the worldwide myositis community. TMA Myositis Africa was established as our newest regional support group, with support from the TMA Women of Color Affinity Group. Two new research grants were approved, in myositis-associated interstitial lung disease and predictive modeling of inclusion body myositis. Two investigators with TMA-funded projects concluded their studies in 2023, with findings on immune checkpoint inhibitor-induced myositis and the pathological role of B cells in myositis. TMA continued our long-running International Annual Patient Conference, hosted the "Beyond Limits" virtual summit during Myositis Awareness Month, and partnered with the Kansas University Medical Center on a virtual Regional Conference for Myositis Patients.

  • International Annual Patient Conference: TMA has convened myositis patients, care partners, and clinicians for a multi-day conference focused on learning and community-building since 1995. TMA's International Annual Patient Conference (IAPC) is now an annual event with panels of medical experts, peer counseling, sessions on coping skills, exercise workshops, and time to meet other patients and their families. The 2023 IAPC took place in San Diego, Calif., US, from Sept. 7-10. The conference included TMA's Heroes In The Fight Awards presentation, and a virtual recordings package to extend the reach of our conference breakout sessions. Many of TMA's members are not able to travel, due to the progressively debilitating nature of their form of myositis. TMA offers the conference recordings at a discounted price to share the learnings from TMA's IAPC as widely and inclusively as possible.

    Expenses $382,541 · Grants $598 · Revenue $80,624

  • Research Grants: TMA aims to identify the underlying causes and natural progression of myositis, develop better treatments and more effective therapies, and ultimately to arrive at cures for this collection of disabling diseases. Through our research program, we progress toward a world without myositis. Scientists, practicing physicians, and other medical professionals have supported TMA through our active Medical Advisory Board. This group provides medical information to staff and patients, and guides the TMA research program. TMA recognizes that the myositis patient's best hope for a cure lies in research. More than a dozen TMA grants were active in 2023, including a research fellowship program to attract and encourage post-doctoral trainees (PhD and MD) and early-career physicians to pursue careers in the field of myositis research. TMA also funded innovative pilot projects that will support larger funding opportunities. From 2002 to 2023, TMA has awarded 66 research grants totaling nearly $8 million. Funding has been designed to advance our collective understanding of inclusion body myositis, dermatomyositis, polymyositis, necrotizing myopathy, and all forms of myositis.

    Expenses $377,670 · Grants $227,443

  • Other Program Services: TMA's other initiatives are focused on awareness, advocacy, and clinician outreach. We are continually updating approximately 13,000 members through monthly e-newsletters, quarterly magazines, videos on YouTube, social media channels, and the highly trafficked website myositis.org. Our efforts to elevate the understanding of myositis among the general public are very important. Because these diseases are very rare, advocacy on behalf of the families affected by myositis is a core component of our mission. In 2023, we organized Myositis Awareness Month from May 1-31, 2023 and we participated in World Myositis Day on September 21, 2023. TMA also provides resources for healthcare professionals, to ensure that they receive the latest information on treating myositis and communicating effectively with their patients. We publish various resources, including our "Myositis 101" physician booklets, disease overview brochures, and infographics about health equity, nutrition for autoimmune patients, and more. In 2023, we hosted a myositis research symposium for physicians and experts during our International Annual Patient Conference and we co-hosted a scientific annual meeting with the International Myositis Assessment and Clinical Studies Group (IMACS) and the Cure Juvenile Myositis (JM) Foundation.

    Expenses $241,712

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Rhonda Buckley-Bishop Interim

    Executive Dir.

    Total calculated
    $183,137
    From this org
    $183,137
    From related orgs
    $0
    Other
    $0
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $183,137
    Bonus
    not reported
    Other
    not reported
    Deferred
    not reported
    Nontaxable benefits
    not reported
    Filer's total
    $183,137
  • Chris Thornton Outgoing

    Executive Dir.

    Total calculated
    $20,436
    From this org
    $20,436
    From related orgs
    $0
    Other
    $0
    Hours/week
    40
  • Paula Eichenbrenner Incoming

    Executive Dir.

    Total calculated
    $16,231
    From this org
    $16,231
    From related orgs
    $0
    Other
    $0
    Hours/week
    40
  • Martha Arnold

    Secretary

    Total calculated
    $0
    Hours/week
    1.5
  • Laurie Boyer Vice Chair

    Director

    Total calculated
    $0
    Hours/week
    1.5
  • Jeff Autrey

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Gail Bayliss

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Rex Bickers

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • David Mochel Chair

    Director

    Total calculated
    $0
    Hours/week
    1.5
  • Marianne Moyer

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Ronne Adkins

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Rodger Oren

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Iazsmin Bauer Ventura

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Holly Jones

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Frank Lipiecki

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Rich DeAugustinis

    Treasurer

    Total calculated
    $0
    Hours/week
    1.5
  • Ricky Marks

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Nita Sharma

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Howard Gerrin

    Director

    Total calculated
    $0
    Hours/week
    0.5
  • Tahseen Mozaffar

    Director

    Total calculated
    $0
    Hours/week
    0.5

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Provenance

Return type
form_990
Tax year
2023
Filed
14 November 2024
IRS schema version
2023v5.1
Source object
202423199349315512

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.